Cargando…

Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics

BACKGROUND: One of the challenges in the interpretation of studies showing associations between environmental and genotypic data with disease outcomes such as neovascular age-related macular degeneration (AMD) is understanding the phenotypic heterogeneity within a patient population with regard to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feehan, Michael, Hartman, John, Durante, Richard, Morrison, Margaux A, Miller, Joan W, Kim, Ivana K, DeAngelis, Margaret M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141628/ https://www.ncbi.nlm.nih.gov/pubmed/21682878 http://dx.doi.org/10.1186/1471-2350-12-83

Ejemplares similares

The NEI/NCBI dbGAP database: Genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration
por: Zhang, Hong, et al.
Publicado: (2008)

Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration
por: Kim, Ivana K., et al.
Publicado: (2008)

Quality of Life with Macular Degeneration Is Not as Dark as It May Seem: Patients’ Perceptions of the MacDQoL Questionnaire
por: Ord, Lisa M., et al.
Publicado: (2015)

Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors
por: Pennington, Katie L., et al.
Publicado: (2016)

Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration
por: Woo, Se Joon, et al.
Publicado: (2015)

Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration
por: Hageman, Gregory S, et al.
Publicado: (2011)

Ancestry of the Timorese: age-related macular degeneration associated genotype and allele sharing among human populations from throughout the world
por: Morrison, Margaux A., et al.
Publicado: (2015)

Contribution of common and rare variants to Asian neovascular age-related macular degeneration subtypes
por: Fan, Qiao, et al.
Publicado: (2023)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

Angiographic Subtypes of Neovascular Age-related Macular Degeneration in Korean: A New Diagnostic Challenge
por: Bae, Kunho, et al.
Publicado: (2019)

Bone Morphogenetic Protein (BMP)4 But Not BMP2 Disrupts the Barrier Integrity of Retinal Pigment Epithelia and Induces Their Migration: A Potential Role in Neovascular Age-Related Macular Degeneration
por: Ibrahim, Ahmed S., et al.
Publicado: (2020)

Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)

Subthreshold Exudative Choroidal Neovascularization (CNV): Presentation of This Uncommon Subtype and Other CNVs in Age-Related Macular Degeneration (AMD)
por: Douglas, Vivian Paraskevi, et al.
Publicado: (2022)

Influence of ROBO1 and RORA on Risk of Age-Related Macular Degeneration Reveals Genetically Distinct Phenotypes in Disease Pathophysiology
por: Jun, Gyungah, et al.
Publicado: (2011)

Factors predicting self-reported medication low adherence in a large sample of adults in the US general population: a cross-sectional study
por: Feehan, Michael, et al.
Publicado: (2017)

Radiation therapy for neovascular age-related macular degeneration
por: Petrarca, Robert, et al.
Publicado: (2011)

Experimental Models in Neovascular Age Related Macular Degeneration
por: Rastoin, Olivia, et al.
Publicado: (2020)

Pipeline therapies for neovascular age related macular degeneration
por: Arepalli, Sruthi, et al.
Publicado: (2021)

Association of neovascular age-related macular degeneration with migraine
por: Kuang, Tung-Mei, et al.
Publicado: (2022)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients
por: Mitchell, Sabrina L., et al.
Publicado: (2021)

Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
por: Arrigo, Alessandro, et al.
Publicado: (2021)

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
por: Ferro Desideri, Lorenzo, et al.
Publicado: (2023)

Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR
por: Freund, K. Bailey, et al.
Publicado: (2022)

Segmentation of macular neovascularization and leakage in fluorescein angiography images in neovascular age-related macular degeneration using deep learning
por: Holomcik, David, et al.
Publicado: (2022)

Genome-Wide Pleiotropy Study Identifies Association of PDGFB with Age-Related Macular Degeneration and COVID-19 Infection Outcomes
por: Chung, Jaeyoon, et al.
Publicado: (2022)

Age-Related Macular Degeneration: Advances in Management and Diagnosis
por: Yonekawa, Yoshihiro, et al.
Publicado: (2015)

Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008)

Treatment of neovascular age-related macular degeneration: Current therapies
por: Augustin, Albert J, et al.
Publicado: (2009)

Treatment of neovascular age-related macular degeneration in patients with diabetes
por: Cummings, Michael, et al.
Publicado: (2008)

Phacoemulsification Surgery in Eyes with Neovascular Age-Related Macular Degeneration
por: Grixti, Andre, et al.
Publicado: (2014)

Profile of conbercept in the treatment of neovascular age-related macular degeneration
por: Lu, Xinmin, et al.
Publicado: (2015)

Treatment of age-related neovascular macular degeneration: the patient’s perspective
por: Müller, S., et al.
Publicado: (2017)

Spironolactone as an Adjunctive Treatment in Neovascular Age-Related Macular Degeneration
por: Kapoor, Kapil G., et al.
Publicado: (2017)

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
por: Kapoor, Kapil G., et al.
Publicado: (2016)

Progression of subclinical choroidal neovascularization in age-related macular degeneration
por: Heiferman, Michael J., et al.
Publicado: (2019)

Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020
por: Samanta, Anindya, et al.
Publicado: (2020)

Levodopa Positively Affects Neovascular Age-Related Macular Degeneration
por: Figueroa, Anna G., et al.
Publicado: (2020)

Personalized Approach in Treatment of Neovascular Age-Related Macular Degeneration
por: Kirkova, Radina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nhjslje8utnvh9c26jp3j1r8jg